Testosterone deficiency is associated with increased risk of mortality and testosterone replacement improves survival in men with type 2 diabetes
Top Cited Papers
- 1 December 2013
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in Acta Endocrinologica
- Vol. 169 (6), 725-733
- https://doi.org/10.1530/eje-13-0321
Abstract
Objective: Men with type 2 diabetes are known to have a high prevalence of testosterone deficiency. No long-term data are available regarding testosterone and mortality in men with type 2 diabetes or any effect of testosterone replacement therapy (TRT). We report a 6-year follow-up study to examine the effect of baseline testosterone and TRT on all-cause mortality in men with type 2 diabetes and low testosterone.Research design and methods: A total of 581 men with type 2 diabetes who had testosterone levels performed between 2002 and 2005 were followed up for a mean period of 5.8±1.3 s.d. years. Mortality rates were compared between total testosterone >10.4 nmol/l (300 ng/dl; n=343) and testosterone ≤10.4 nmol/l (n=238). The effect of TRT (as per normal clinical practise: 85.9% testosterone gel and 14.1% intramuscular testosterone undecanoate) was assessed retrospectively within the low testosterone group.Results: Mortality was increased in the low testosterone group (17.2%) compared with the normal testosterone group (9%; P=0.003) when controlled for covariates. In the Cox regression model, multivariate-adjusted hazard ratio (HR) for decreased survival was 2.02 (P=0.009, 95% CI 1.2–3.4). TRT (mean duration 41.6±20.7 months; n=64) was associated with a reduced mortality of 8.4% compared with 19.2% (P=0.002) in the untreated group (n=174). The multivariate-adjusted HR for decreased survival in the untreated group was 2.3 (95% CI 1.3–3.9, P=0.004).Conclusions: Low testosterone levels predict an increase in all-cause mortality during long-term follow-up. Testosterone replacement may improve survival in hypogonadal men with type 2 diabetes.Keywords
This publication has 39 references indexed in Scilit:
- Endogenous Testosterone and Mortality in Men: A Systematic Review and Meta-AnalysisJournal of Clinical Endocrinology & Metabolism, 2011
- Low Testosterone Associated With Obesity and the Metabolic Syndrome Contributes to Sexual Dysfunction and Cardiovascular Disease Risk in Men With Type 2 DiabetesDiabetes Care, 2011
- Low serum testosterone and increased mortality in men with coronary heart diseaseHeart, 2010
- Gonadal and adrenal androgen deficiencies as independent predictors of increased cardiovascular mortality in men with type II diabetes mellitus and stable coronary artery diseaseInternational Journal of Cardiology, 2010
- Low Serum Testosterone and Mortality in Older MenJournal of Clinical Endocrinology & Metabolism, 2008
- Endogenous Testosterone and Mortality Due to All Causes, Cardiovascular Disease, and Cancer in MenCirculation, 2007
- Clinical and Biochemical Assessment of Hypogonadism in Men With Type 2 DiabetesDiabetes Care, 2007
- Sex Differences of Endogenous Sex Hormones and Risk of Type 2 DiabetesJAMA, 2006
- Frequent Occurrence of Hypogonadotropic Hypogonadism in Type 2 DiabetesJournal of Clinical Endocrinology & Metabolism, 2004
- Endogenous sex hormones and cardiovascular disease in men. A prospective population-based study.Circulation, 1988